| top of page |
| Details of the target gene |
| Gene Model of Rodent Parasite |
PBANKA_0818100
|
| Gene Model P. falciparum ortholog |
PF3D7_0917100
|
| Gene product | N-glycosylase/DNA lyase, putative |
| Gene product: Alternative name | OGG1; PbOgg1 |
| top of page |
| Details of the genetic modification |
| Inducable system used | No |
| Additional remarks inducable system |
|
| Type of plasmid/construct used | (Linear) plasmid double cross-over |
| PlasmoGEM (Sanger) construct/vector used | No |
| Modified PlasmoGEM construct/vector used | No
|
| Plasmid/construct map |
|
| Plasmid/construct sequence |
|
| Restriction sites to linearize plasmid |
|
| Partial or complete disruption of the gene | Complete |
| Additional remarks partial/complete disruption |
|
| Selectable marker used to select the mutant parasite | hdhfr/yfcu |
| Promoter of the selectable marker | eef1a |
| Selection (positive) procedure | pyrimethamine |
| Selection (negative) procedure | No |
| Additional remarks genetic modification | To disrupt PbOgg1, two fragments - F1 (0.54 kb) and F2 (0.57 kb) - encompassing the 5′ and 3′ untranslated regions (UTRs) were amplified using primers 1401/1402 and 1403/1404, respectively, and cloned in plasmid pBC-GFPhDHFR:yFCU. The integration cassette was released from the plasmid backbone by digestion with XhoI/AscI. |
| Additional remarks selection procedure | |
Primer information: Primers used for amplification of the target sequences 
Primer information: Primers used for amplification of the target sequences
| Sequence Primer 1 | |
| Additional information primer 1 | |
| Sequence Primer 2 | |
| Additional information primer 2 | |
| Sequence Primer 3 | |
| Additional information primer 3 | |
| Sequence Primer 4 | |
| Additional information primer 4 | |
| Sequence Primer 5 | |
| Additional information primer 5 | |
| Sequence Primer 6 | |
| Additional information primer 6 | |
|
| top of page |